MARK A BLUMBERG M.D. NPI 1588662019

NPI Details

Mark A Blumberg, M.D. is a dermatology in Springfield, MA with 26 years of experience. The provider is a dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging. Mark A Blumberg, M.D. NPI is 1588662019. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Graduation Year:2000

The provider's business location address is:

3455 MAIN ST
SUITE 5
SPRINGFIELD, MA
ZIP 01107-147
Phone: (413) 733-9600
Fax: (413) 732-6534

The NPI 1588662019 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Destruction of precancer skin growth, 2-14 growths (HCPCS:17003)
• Destruction of precancer skin growth, 1 growth (HCPCS:17000)
• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Biopsy of related skin growth, first growth (HCPCS:11102)
• Destruction of skin growth, 1-14 growths (HCPCS:17110)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Therapy procedure using ultraviolet radiation with tar or petroleum jelly application (HCPCS:96910)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm (HCPCS:17261)
• Biopsy of related skin growth, each additional growth (HCPCS:11103)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.6-1.0 cm (HCPCS:17271)
• Destruction of cancer skin growth of trunk, arms, or legs, 0.5 cm or less (HCPCS:17260)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm (HCPCS:17262)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.5 cm or less (HCPCS:17280)
• Injection into skin growth, 1-7 growths (HCPCS:11900)
• New patient office or other outpatient visit, 15-29 minutes (HCPCS:99202)
• Biopsy of ear (HCPCS:69100)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm (HCPCS:17281)
• Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) (HCPCS:J7308)
• Application of light to destroy precancer skin growth (HCPCS:96567)
• Simple or single drainage of skin abscess (HCPCS:10060)
• Shaving of skin growth of body, arms, or legs, 0.6-1.0 cm (HCPCS:11301)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 0.5 cm or less (HCPCS:17270)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
• Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
• Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm (HCPCS:12032)
• Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm (HCPCS:17282)
• Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm (HCPCS:17272)
• All potassium hydroxide (koh) preparations (HCPCS:Q0112)
• Shaving of skin growth of body, arms, or legs, 0.5 cm or less (HCPCS:11300)
• Melanoma (skin cancer) excision (HCPCS:NAN03)

The enumeration date for this NPI number is 7/8/2005 and was last updated on 11/8/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.